Americans are increasingly calling poison control centers over semaglutide, the active ingredient in popular weight loss drugs Ozempic and Wegovy. Most of these calls appear to concern potential overdoses of semaglutide and might be tied to a rise in compounded versions of the drug, which aren’t tested for their…
Americans are increasingly calling poison control centers over semaglutide, the active ingredient in popular weight loss drugs Ozempic and Wegovy. Most of these calls appear to concern potential overdoses of semaglutide and might be tied to a rise in compounded versions of the drug, which aren’t tested for their…Read more… Read More poison, anti obesity medication, compounding, health medical pharma, drug overdose, semaglutide, dose, peptide therapeutics, poison control center, transient ischemic attack, kait brown, novo nordisk, peptide hormones Gizmodo
